Sign in
4

Changes in Ownership

Cardiff Oncology, Inc. Filed Acc 0001641172-25-017071

Options or other derivatives

  • Director acquired 40,565 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Markin Rodney S · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-06-26 Grant or award : show line 1 in the form Stock Options +40,565 222,865 D
Loading xslF345X05/ownership.xml…